Amin Pharmaceutical Co (XTEH:AMIN1) Interest Expense : IRR Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Amin Pharmaceutical Co's interest expense for the six months ended in . 20 was IRR 0.00 Mil. Amin Pharmaceutical Co does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Amin Pharmaceutical Co's Operating Income for the six months ended in . 20 was IRR 0.00 Mil. Amin Pharmaceutical Co's Interest Expense for the six months ended in . 20 was IRR 0.00 Mil. Amin Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amin Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Amin Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Interest Expense Chart

Amin Pharmaceutical Co Annual Data

Trend

Interest Expense

Amin Pharmaceutical Co Semi-Annual Data

Interest Expense

Amin Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Amin Pharmaceutical Co (XTEH:AMIN1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amin Pharmaceutical Co's Interest Expense for the six months ended in . 20 was IRR0.00 Mil. Its Operating Income for the six months ended in . 20 was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was IRR0.00 Mil.

Amin Pharmaceutical Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Amin Pharmaceutical Co had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN

Website

https://www.aminpharma.com

Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines